New Insights in Peripartum Cardiomyopathy. Obstet Gynecol Clin North Am 2018 Jun;45(2):281-298
Date
05/12/2018Pubmed ID
29747731DOI
10.1016/j.ogc.2018.02.002Scopus ID
2-s2.0-85046634893 (requires institutional sign-in at Scopus site) 6 CitationsAbstract
Significant progress in understanding the pathophysiology of peripartum cardiomyopathy, especially hormonal and genetic mechanisms, has been made. Specific criteria should be used for diagnosis, but the disease remains a diagnosis of exclusion. Both long-term and recurrent pregnancy prognoses depend on recovery of cardiac function. Data from large registries and randomized controlled trials of evidence-based therapeutics hold promise for future improved clinical outcomes.
Author List
Cruz MO, Briller J, Hibbard JUAuthor
Meredith Cruz MD Professor in the Obstetrics and Gynecology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
CardiomyopathiesFemale
Heart Failure
Humans
Peripartum Period
Pregnancy
Pregnancy Complications, Cardiovascular
Puerperal Disorders









